Dopamine Agonists in Parkinson’s DiseaseWhat is Their Role in Early Treatment?

被引:0
作者
Fabrizio Stocchi
机构
[1] University ‘La Sapienza’ of Rome and ‘Neuromed’ Pozzilli (IS),Department of Neuroscience
来源
CNS Drugs | 1998年 / 10卷
关键词
Levodopa; Adis International Limited; Bromocriptine; Dopamine Agonist; Apomorphine;
D O I
暂无
中图分类号
学科分类号
摘要
Dopamine receptor agonists are pharmacological agents with diverse physical and chemical properties that share the capacity to stimulate dopamine receptors and provide an antiparkinsonian effect. Currently available dopamine agonists belong to 2 classes: ergot (bromocriptine, lisuride, pergolide, cabergoline) and non-ergot (apomorphine, ropinirole, pramipexole) derivatives, each having a different pharamacological profile and different affinity for the dopaminergic receptors and subtypes.
引用
收藏
页码:159 / 170
页数:11
相关论文
共 149 条
[1]  
Sweet RD(1975)Five years’treatment of Parkinson’s disease with levodopa Ann Intern Med 83 456-63
[2]  
McDowell FH(1979)Analysis of the clinical problem in parkinsonism and the complications of long term levodopa therapy Neurology 29 1253-60
[3]  
Lesser RD(1997)Levodopa-induced neurotoxicity: does it represent a problem for the treatment of Parkinson’s disease? CNS Drugs 8 376-93
[4]  
Fahn S(1974)Bromocriptine in parkinsonism BMJ 4 442-4
[5]  
Snider SR(1985)Combined bromocriptine-levodopa therapy early in Parkinson’s disease Neurology 35 1196-8
[6]  
Fahn S(1990)Bromocriptine and levodopa in early combination in Parkinson’s disease: first results of the Collaborative European Multicentric Trial Adv Neurol 53 421-3
[7]  
Calne DB(1993)Early combination therapy with bromocriptine and levodopa in Parkinson’s disease Mov Disord 8 257-62
[8]  
Teychenne PF(1989)A randomized controlled study of bromocriptine versus levodopa in previously un-treated parkinsonian patients: a 3 year follow-up J Neurol Neurosurg Psychiatry 52 773-5
[9]  
Claveria LE(1987)Early combination of bromocriptine and levodopa in the treatment of Parkinson’s disease: a 5-year follow-up Neurology 37 826-8
[10]  
Rinne UK(1993)Treatment of Parkinson’s disease N Engl J Med 329 1021-7